ARTICLE | Clinical News
Boehringer Ingelheim Pharmaceuticals Inc. regulatory update
May 3, 1999 7:00 AM UTC
The FDA's Peripheral & Central Nervous System Drugs Advisory Committee voted unanimously to recommend approval of Aggrenox extended-release dipyridamole capsules to prevent recurrent stroke in patien...